US equities |
MU $953.19 ▼-3.62% NVDA $228.52 ▲+0.97% META $762.50 ▲+2.63% AAPL $341.27 ▲+0.09% MSFT $543.45 ▲+0.43% SNDK $1,482.33 ▼-0.34% AMD $605.53 ▲+1.90% SPCX $156.54 ▼-4.21%
FinancialContent

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ:CRBP)

4.780 -0.490 (-9.30%)
Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
News headline image
Corbus Pharmaceuticals stock: An explosive 342% YTD surge
Shares of CRBP have already experienced a meteoric rise of over 300% year-to-date, thanks to early but promising data from its Phase 1 trial. 
Via MarketBeat
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
Via Get News
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
New York, Jan. 29, 2024 - (Plato Data) -- Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug... 
Via TheNewswire.com
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a Leading Gainer in 1/26 Morning Trading
Via Investor Brand Network
News headline image
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /... 
From JTC Team, LLC
Via AccessWire